Skip to main content
Screener/Healthcare/Biotechnology

GALT Galectin Therapeutics Inc.

NASDAQ
$3.15+0.34 (+12.14%)
$2.02
$7.13
$2.71
$3.70
EPS (TTM)$-0.48
P/E Ratio-4.81
Dividend Yield
Market Cap$216.0M
Volume3.57M
Prev Close$2.80
Financial data is not available for this stock.
Get Your Daily Market Recap